Our Mission
The Scientific Technology Assessment Research Team (START), led by Stephanie Pond, Ph.D., Vice President of Emerging Technologies, is a dedicated group at TGen with the aim to accelerate the evaluation of pre-commercial technologies that have the power to broadly impact scientific research at TGen and City of Hope.
Our Strategy
- START is a team of scientists that works with faculty to identify technology gaps and opportunities.
- We then connect with industry partners outside of TGen and coordinate agreements to enable collaboration.
- We utilize characterized, biological relevant samples to evaluate new technology with the faculty and leading industry partners.
- Together we create high-impact pilot projects to demonstrate the impact of new technology on patient health.
TGen explores the next-level accuracy of Onso short-read sequencing.
In this illuminating video, Candice Wike, Ph.D., from the Translational Genomics Research Institute (TGen), part of City of Hope, joins Product Marketer Young Kim in Menlo Park. During their conversation they take us on a journey through the remarkable world of TGen’s research and highlights the game-changing potential of this advanced technology.
In this illuminating video, Candice Wike, Ph.D., from the Translational Genomics Research Institute (TGen), part of City of Hope, joins Product Marketer Young Kim in Menlo Park. During their conversation they take us on a journey through the remarkable world of TGen’s research and highlights the game-changing potential of this advanced technology.